CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 55 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $0 | – | 30 | 0.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 30 | -99.7% | 0.00% | – |
Q3 2019 | $3,000 | -87.0% | 10,830 | -87.6% | 0.00% | – |
Q2 2019 | $23,000 | -76.8% | 87,494 | -5.0% | 0.00% | – |
Q1 2019 | $99,000 | -38.1% | 92,104 | -0.2% | 0.00% | – |
Q4 2018 | $160,000 | -78.2% | 92,283 | -26.9% | 0.00% | – |
Q3 2018 | $733,000 | +21.8% | 126,314 | -10.2% | 0.00% | – |
Q2 2018 | $602,000 | +28.1% | 140,687 | +75.7% | 0.00% | – |
Q1 2018 | $470,000 | +459.5% | 80,083 | +339.8% | 0.00% | – |
Q4 2017 | $84,000 | +189.7% | 18,211 | +255.6% | 0.00% | – |
Q3 2017 | $29,000 | -6.5% | 5,121 | -6.3% | 0.00% | – |
Q2 2017 | $31,000 | +244.4% | 5,468 | +248.7% | 0.00% | – |
Q1 2017 | $9,000 | +50.0% | 1,568 | -45.1% | 0.00% | – |
Q3 2016 | $6,000 | +20.0% | 2,856 | +26.3% | 0.00% | – |
Q2 2016 | $5,000 | 0.0% | 2,262 | +6.0% | 0.00% | – |
Q1 2016 | $5,000 | -97.7% | 2,133 | -90.9% | 0.00% | – |
Q2 2014 | $214,000 | – | 23,524 | +213754.5% | 0.00% | – |
Q1 2014 | $0 | – | 11 | +1000.0% | 0.00% | – |
Q4 2013 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
Quilter Plc | 60,546 | $19,000 | 0.00% |
ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
BlackRock Inc. | 645,611 | $200,000 | 0.00% |
Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |